UK Public Borrowing Hits Highest Level Since Covid Era in April as Retail Sales Decline Amid Fuel Price Surge California State of Emergency Declared Over Methyl Methacrylate Leak Potential Chemical Sector Disruptions India Energy Investment Set to Reach 170 Billion by 2026 Driven by Solar Grid and Refining IEA The Perils of Chasing Returns Why Investors Should Prioritize LongTerm Discipline UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister Veeco Instruments Inc Insider Files Form 144 for Planned Share Sale Icahn Enterprises Q1 2026 Earnings Significant EPS Miss Amid Investment Volatility IMO Q1 2026 Earnings EPS Misses Estimates Amid Challenging Energy Market ProAssurance Corporation PRA Q1 2026 Earnings EPS Misses Estimates as Underwriting Pressures Mount Alumis Inc ALMS Q1 2026 Earnings Narrower Loss Mirrors Operational Discipline PreRevenue Stage Persists OLB Group Q4 2025 Earnings Narrowed Loss Beats Estimates Shares Rise TELO Q4 2025 Earnings EPS Misses Estimates by 292 as Cash Burn Continues No Revenue Reported Aditxt ADTX Plunges 43 to 069 Technical Damage and Key Levels to Watch Binah Capital Group BCG Faces Selling Pressure as Shares Dip Below Key Support Zone Arcturus Therapeutics ARCT Surges 62 as Buyers Defend Key Support BrightView Holdings BV Edges Higher Testing Key Resistance Zone AEFC Holds Steady at 1917 Amid Low Volatility FixedIncome Stability in Focus Potential IranUS MoU Could Include Oil Sanctions Waiver and Nuclear Talks Timeline VEEV Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Amid Steady Execution Immutep Limited IMMP Edges Higher as Biotech Stock Tests Key Resistance at 051 SMID Q4 2023 Earnings Reports Positive EPS of 004 Revenue Details Unavailable AirSculpt Technologies Q1 2026 Earnings EPS Beats Estimates Despite Loss Stock Rises Atossa Therapeutics Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances Neogen Corporation NEOG Q1 2026 Earnings Strong Profit Beat Offsets Flat Revenue Galectin Therapeutics Q1 2026 Earnings EPS Misses Estimates Stock Rallies on Operational Progress KURA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports WiderThanExpected Loss RMBI Q1 2026 Earnings Solid EPS Amidst Flat Market Reaction